about
Effects of local serotonin administration on pain and microcirculation in the human masseter muscle.Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle.Temporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatmentRepeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.The associations between psychosocial aspects and TMD-pain related aspects in children and adolescents.Prevalence of diagnosed temporomandibular disorders among Saudi Arabian children and adolescentsPerceived Oral Health and Care of Children with Juvenile Idiopathic Arthritis: A Qualitative Study.Symptoms and signs of temporomandibular disorders in patients with sudden sensorineural hearing loss.Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis - an observational study.Orofacial pain and dysfunction in children with juvenile idiopathic arthritis: a case-control study.Patients' experience of care and treatment outcome at the Department of Clinical Oral Physiology, Dental Public Service in Stockholm.Presence of orofacial pain and temporomandibular disorder in fibromyalgia. A study by questionnaireEffect of local glucocorticoid injection on masseter muscle level of serotonin in patients with chronic myalgiaPain, allodynia, and serum serotonin level in orofacial pain of muscular originEffects of isometric contraction on intramuscular level of neuropeptide Y and local pain perceptionIntraoral condition in children with juvenile idiopathic arthritis compared to controlsEfficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study
P50
Q33254190-B347B704-1F8F-4C81-AF77-08DC3C7E2C99Q34112990-5167FE8D-CB2A-4FD7-9C36-0CE5DF3ADC69Q34227357-C3EAA1A8-6F80-4F4C-9455-C17BFD44A117Q36345839-C62BDFA5-5D1B-4D43-A1EC-AA52D5C01DA0Q36764119-7E90975B-1809-464A-8F0E-8498B6D87834Q36823475-EEEB321A-2F7A-45EF-B3F3-2F0BF492F138Q38977474-BEFC9955-1BB8-4AB2-913C-C101A129BDEEQ39911059-9F54A0FE-F995-43EC-B554-9CB6BFE1222EQ42839459-2675F89B-FFC0-406E-AEF7-C1C3E72017A6Q45808274-48541368-E2E8-4FE9-A23C-110AAC0E5662Q51770030-F124D2C7-52BA-4901-8BA1-80196A429E9FQ74020230-30664FFE-37FC-486D-B9A9-8C85D5F8F1A6Q74830758-71A33E1A-D664-4E4E-8A41-C4A66B9F22E7Q78058896-8350457A-C6AB-419D-938B-7AA356F3E349Q79379376-71DD644C-C9D2-4124-B34E-3FC619D1AFC9Q81661313-5F0422E9-9828-4CFC-B901-20F39A65B57BQ83938579-AF9A6623-F722-4CF2-8797-FA69841BA762
P50
description
researcher ORCID ID = 0000-0002-5911-5166
@en
wetenschapper
@nl
name
Britt Hedenberg-Magnusson
@ast
Britt Hedenberg-Magnusson
@en
Britt Hedenberg-Magnusson
@es
Britt Hedenberg-Magnusson
@nl
type
label
Britt Hedenberg-Magnusson
@ast
Britt Hedenberg-Magnusson
@en
Britt Hedenberg-Magnusson
@es
Britt Hedenberg-Magnusson
@nl
prefLabel
Britt Hedenberg-Magnusson
@ast
Britt Hedenberg-Magnusson
@en
Britt Hedenberg-Magnusson
@es
Britt Hedenberg-Magnusson
@nl
P31
P496
0000-0002-5911-5166